GlassScriptPhysician profile
Alaaeldin Moawad
NPI 1396835047
$644.42
in general payments reported to CMS, 2019-2025
8 companies · $74.89 in 2025
The $74.89 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.27 · 2020: $114 · 2021: $77.52 · 2022: $125 · 2023: $68.00 · 2024: $101 · 2025: $74.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $243.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $346.90 | 2019-2023 | Bexsero |
| Pfizer INC. | $101.26 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $66.43 | 2024 | Gardasil 9, Gardasil, Vaxelis |
| Cranial Technologies, INC | $40.89 | 2021-2023 | Doc Band |
| Alexion Pharmaceuticals, INC. | $34.64 | 2024 | Koselugo |
| Sanofi Pasteur INC. | $22.29 | 2025 | |
| Qiagen, LLC | $16.92 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.09 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alaaeldin Moawad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.